WHO ICTRP trial
Dutch-Belgian pediatric AML protocol for children with newly diagnosed acute…
EUCTR2009-014462-26-BE · EU Clinical Trials Register · Not Recruiting
Key facts
| Trial ID | EUCTR2009-014462-26-BE |
|---|---|
| Public title | Dutch-Belgian pediatric AML protocol for children with newly diagnosed acute myeloid leukemia, based on the NOPHO-AML 2004 study |
| Scientific title | Dutch-Belgian pediatric AML protocol for children with newly diagnosed acute myeloid leukemia, based on the NOPHO-AML 2004 study |
| Primary sponsor | Ghent University Hospital |
| Registry | EU Clinical Trials Register |
| Recruitment status | Not Recruiting |
| Study type | Interventional clinical trial of medicinal product |
| Phase | Human pharmacology (Phase I): no Therapeutic exploratory (Phase II): no Therapeutic confirmatory - (Phase III): yes Therapeutic use (Phase IV): no |
| Countries | Belgium |
| Conditions | Acute Myeloid Leukemia in children MedDRA version: 13.1 Level: LLT Classification code 10000886 Term: Acute myeloid leukemia System Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps) ;Therapeutic… |
| Interventions | Trade Name: Cytosar 100 mg Product Name: Cytarabine Pharmaceutical Form: Solution for injection INN or Proposed INN: CYTARABINE CAS Number: 147-94-4 Concentration unit: mg milligram(s) Concentration type: equal Concentration number: 100… |
| Registration date | Aug 2, 2010 |
| Target size | 140 |
| Secondary IDs | DB-AML-01 |
| Registry page | clinicaltrialsregister.eu |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: